Veru Inc. is an oncology and urology biopharmaceutical company developing and commercializing novel medicines for the prostate cancer continuum of care and urology specialty pharmaceuticals.
December 12, 2019
Listen to other presentations and conference calls
PARTICIPANT DIAL IN (TOLL FREE): 1-800-341-1602
PARTICIPANT INTERNATIONAL DIAL IN: 1-412-902-6706
Please ask to be joined into the Veru Inc call.
October 2, 2019
Watch the replay of the webcast of our presentation at the 2019 Cantor Fitzgerald Global Healthcare Conference.
(View Slide Deck)
January 21, 2020
Veru Announces Acceptance of Two Abstracts for Presentation at the Genitourinary Cancer Symposium in February 2020
January 13, 2020
Veru Announces Positive Top-Line Interim Data from Phase 2 Clinical Trial of Zuclomiphene to Treat Hot Flashes in Men with Prostate Cancer on Androgen Deprivation Therapy